These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23610954)

  • 21. Accessing lipophilicity of drugs with biomimetic models: A comparative study using liposomes and micelles.
    Loureiro DRP; Soares JX; Lopes D; Macedo T; Yordanova D; Jakobtorweihen S; Nunes C; Reis S; Pinto MMM; Afonso CMM
    Eur J Pharm Sci; 2018 Mar; 115():369-380. PubMed ID: 29366962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the n-octanol/water partition coefficients of weakly ionizable basic compounds by reversed-phase high-performance liquid chromatography with neutral model compounds.
    Liang C; Han SY; Qiao JQ; Lian HZ; Ge X
    J Sep Sci; 2014 Nov; 37(22):3226-34. PubMed ID: 25212740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico estimation of basic activity-relevant parameters for a set of drug absorption promoters.
    Bak A; Kozik V; Smolinski A; Jampilek J
    SAR QSAR Environ Res; 2017 Jun; 28(6):427-449. PubMed ID: 28573881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromatographic lipophilicity determination using large volume injections of the solvents non-miscible with the mobile phase.
    Sârbu C; Naşcu-Briciu RD; Casoni D; Kot-Wasik A; Wasik A; Namieśnik J
    J Chromatogr A; 2012 Nov; 1266():53-60. PubMed ID: 23102869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of lipophilicity in drug discovery and design.
    Arnott JA; Planey SL
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemodiversity and molecular plasticity: recognition processes as explored by property spaces.
    Vistoli G; Pedretti A; Testa B
    Future Med Chem; 2011 Jun; 3(8):995-1010. PubMed ID: 21707401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of physicochemical properties of small molecules by reversed-phase liquid chromatography.
    Poole CF; Atapattu SN
    J Chromatogr A; 2020 Aug; 1626():461427. PubMed ID: 32739066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling of retention of pesticides in reversed-phase high-performance liquid chromatography: quantitative structure-retention relationships based on solute quantum-chemical descriptors and experimental (solvatochromic and spin-probe) mobile phase descriptors.
    D'Archivio AA; Ruggieri F; Mazzeo P; Tettamanti E
    Anal Chim Acta; 2007 Jun; 593(2):140-51. PubMed ID: 17543600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Lipophilicity in Drug Discovery: Rapid Measurements by Means of Reversed-Phase HPLC.
    Giaginis C; Tsopelas F; Tsantili-Kakoulidou A
    Methods Mol Biol; 2018; 1824():217-228. PubMed ID: 30039409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micellar liquid chromatography for lipophilicity determination of new biologically active 1,3-purinodiones.
    Kawczak P; Vander Heyden Y; Nasal A; Baczek T; Drabczyñska A; Kieć-Kononowicz K; Kaliszan R
    J Sep Sci; 2010 Jun; 33(11):1546-57. PubMed ID: 20373294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partition coefficient vs. binding constant: How best to assess molecular lipophilicity.
    Cevc G
    Eur J Pharm Biopharm; 2015 May; 92():204-15. PubMed ID: 25794476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Going further than Lipinski's rule in drug design.
    Walters WP
    Expert Opin Drug Discov; 2012 Feb; 7(2):99-107. PubMed ID: 22468912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipophilicity determination of highly lipophilic compounds by liquid chromatography.
    Guillot A; Henchoz Y; Moccand C; Guillarme D; Veuthey JL; Carrupt PA; Martel S
    Chem Biodivers; 2009 Nov; 6(11):1828-36. PubMed ID: 19937824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of solubility of drugs and other compounds in organic solvents.
    Abraham MH; Smith RE; Luchtefeld R; Boorem AJ; Luo R; Acree WE
    J Pharm Sci; 2010 Mar; 99(3):1500-15. PubMed ID: 19774653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of calculated and experimental parameters as sources of structural information: the case of lipophilicity-related descriptors.
    Caron G; Ermondi G
    Mini Rev Med Chem; 2003 Dec; 3(8):821-30. PubMed ID: 14529501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
    Bard B; Carrupt PA; Martel S
    J Med Chem; 2009 May; 52(10):3416-9. PubMed ID: 19397318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSRR: quantitative structure-(chromatographic) retention relationships.
    Kaliszan R
    Chem Rev; 2007 Jul; 107(7):3212-46. PubMed ID: 17595149
    [No Abstract]   [Full Text] [Related]  

  • 40. What determines drug solubility in lipid vehicles: is it predictable?
    Rane SS; Anderson BD
    Adv Drug Deliv Rev; 2008 Mar; 60(6):638-56. PubMed ID: 18089295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.